Clinical trials recruiting in Celle, Germany
4
Recruiting trials
7
Conditions
Phase breakdown
Not applicable 4
Conditions recruiting in Celle, Germany
| Condition | Trials |
|---|---|
| Breast Neoplasms | 1 |
| Breast cancer | 1 |
| Colorectal cancer | 1 |
| Lung cancer | 1 |
| Metastatic Colorectal Carcinoma | 1 |
| Multiple Sclerosis | 1 |
| Non-squamous Metastatic Non-Small-Cell Lung Carcinoma | 1 |
Recruiting trials in Celle, Germany
- A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
- A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)
- BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment
- NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations
Common questions
How many clinical trials are recruiting in Celle, Germany?
4 recruiting trials have at least one study site in Celle, Germany.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.